Korean J Urol.  2014 Feb;55(2):102-105. 10.4111/kju.2014.55.2.102.

Preoperative Erythropoietin Administration in Patients With Prostate Cancer Undergoing Radical Prostatectomy Without Transfusion

• Lee BW
• Park MG
• Cho DY
• Park SS
• Yeo JK

• KMID: 1988434
• DOI: http://doi.org/10.4111/kju.2014.55.2.102

Abstract

PURPOSE
In this study, we administered erythropoietin preoperatively to patients who underwent open radical prostatectomy without transfusion to increase their hemoglobin levels and investigated the efficacy of this procedure.
MATERIALS AND METHODS
We evaluated 62 patients who underwent open radical prostatectomy performed by the same surgeon between June 2005 and January 2011. The 22 patients who refused transfusion were assigned to group 1; the patients who accepted transfusion were assigned to group 2. Before surgery, we administered erythropoietin beta to group 1 patients whose hemoglobin levels were <12 g/dL and retrospectively compared the clinical data of the two groups. We used the t-test and the chi-square test for statistical analysis.
RESULTS
Mean preoperative hemoglobin levels in group 1 after erythropoietin administration (14.5 g/dL) were significantly higher than those in group 2 (13.59 g/dL, p=0.003). Moreover, the difference in the mean hemoglobin levels before and after surgery for group 1 patients (3.55 g/dL) significantly exceeded that for group 2 patients (2.08 g/dL, p=0.000). Additional analysis revealed no statistically significant differences in perioperative complications between the groups.
CONCLUSIONS
Preoperative erythropoietin administration increased the safety margin of hemoglobin levels, and this strategy worked sufficiently well in our experience.

Keyword

Blood transfusion; Bloodless medical and surgical procedures; Erythropoietin; Jehovah's witnesses; Prostatectomy

MeSH Terms

Blood Transfusion
Bloodless Medical and Surgical Procedures
Erythropoietin*
Humans
Jehovah's Witnesses
Prostate*
Prostatectomy*
Prostatic Neoplasms*
Retrospective Studies
Erythropoietin

Reference

1. Lloyd JC, Banez LL, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, et al. Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis. 2009; 12:264–268.

2. Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl. 2005; 87:3–14.

3. Wurnig C, Schatz K, Noske H, Hemon Y, Dahlberg G, Josefsson G, et al. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation. Eur Surg Res. 2001; 33:303–310.

4. Burnett AL, Allaf ME, Bivalacqua TJ. Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis. J Sex Med. 2008; 5:2392–2398.

5. van Haelst IM, Egberts AC, Doodeman HJ, van Solinge WW, Kalkman CJ, Bennis M, et al. Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment. Acta Anaesthesiol Scand. 2013; 57:350–357.

6. Shander A. Acute normovolaemic hemodilution (ANH). A practical approach. TATM. 1999; 1:7–10.

7. Tulloh BR, Brakespear CP, Bates SC, Adams DC, Dalton RG, Richards MJ, et al. Autologous predonation, haemodilution and intraoperative blood salvage in elective abdominal aortic aneurysm repair. Br J Surg. 1993; 80:313–315.

8. Eschwège P, Dumas F, Benoit G, Loric S. Autologous blood transfusion as a potential source of prostate cancer cells spread during radical prostatectomy. Prostate Cancer Prostatic Dis. 1999; 2(S3):S13.

9. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ. Intraoperative cell salvage in radical retropubic prostatectomy. Urology. 2001; 58:740–745.

10. Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011; 343:d5701.

11. McLoughlin PL, Cope TM, Harrison JC. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's witness. Anaesthesia. 1999; 54:891–895.

12. Atabek U, Alvarez R, Pello MJ, Alexander JB, Camishion RC, Curry C, et al. Erythropoetin accelerates hematocrit recovery in post-surgical anemia. Am Surg. 1995; 61:74–77.